Clinical evidence has demonstrated that the anxiolytic effects produced by the selective 5-hydroxytryptamine1A (5-HT1A) receptor agonist, gepirone, increase progressively over one to three weeks of treatment.
| Identifer | oai:union.ndltd.org:unt.edu/info:ark/67531/metadc798440 |
| Date | 08 1900 |
| Creators | Benjamin, Daniel E. (Daniel Ernest) |
| Publisher | University of North Texas |
| Source Sets | University of North Texas |
| Language | English |
| Detected Language | English |
| Type | Thesis or Dissertation |
| Format | Text |
| Rights | Public, Copyright, Copyright is held by the author, unless otherwise noted. All rights |
Page generated in 0.0021 seconds